# Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia

> **NCT02464930** · — · UNKNOWN · sponsor: **Midwest Biomedical Research Foundation** · enrollment: 220 (estimated)

## Conditions studied

- Barrett's Esophagus
- Gastroesophageal Reflux
- Esophageal Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02464930
- **Lead sponsor:** Midwest Biomedical Research Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2018-04
- **Final completion:** 2018-12
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2015-06-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02464930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02464930, "Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02464930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*